精准查“心”病！我国高端医疗装备领域取得新突破

Group 1 - The core viewpoint of the article highlights the upcoming clinical use of a domestically developed fetal magnetocardiography device in Shanghai, which provides new evidence for early screening of complex congenital heart diseases, filling a technological gap in the domestic market [1] - The fetal magnetocardiography device is capable of non-invasive and contactless precise capture of fetal heart signals that traditional devices struggle to identify, representing a significant breakthrough in fetal heart health assessment [3] Group 2 - This innovative achievement has realized a complete innovation chain from technology research and development to industrial transformation, benefiting from the interdisciplinary medical-engineering collaboration established over the past twenty years between Shanghai Jiao Tong University and Shanghai Second Medical University [4] - The universities have implemented an "医+X" innovation model that breaks down traditional disciplinary barriers and supports the cultivation of interdisciplinary talents, alongside establishing a medical-engineering cross-research fund with a cumulative investment of approximately 674 million yuan, providing project funding to multiple medical fields [4]